On the one hand, in CD96−/− mice displaying hypersensitive NK-cell responses to immune challenge and significant tumor resistance (Blake et al., 2016), blocking CD96−CD155 interaction or TGF-β1 restores NK cell immunity against tumors by reversing NK cell exhaustion in liver cancer. This evidence concerns the gene CD96 and neoplasm.